V
46
-2
UAL
64
4
AMGN
31
-11
HPQ
37
-9
GS
65
2
CI
58
-12
JNJ
56
5
MCHP
42
3
IRM
44
-2
MRK
40
-5
TROW
32
11
MMC
65
8
RRC
68
-2
FLR
46
6
AAL
26
2
THC
55
-3
EQIX
53
-4
GD
57
-2
SWKS
40
-2
PCG
62
-4
V
46
-2
UAL
64
4
AMGN
31
-11
HPQ
37
-9
GS
65
2
CI
58
-12
JNJ
56
5
MCHP
42
3
IRM
44
-2
MRK
40
-5
TROW
32
11
MMC
65
8
RRC
68
-2
FLR
46
6
AAL
26
2
THC
55
-3
EQIX
53
-4
GD
57
-2
SWKS
40
-2
PCG
62
-4
Financhill
Back

Royal Bank of Canada Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
64

RY
Royal Bank of Canada

Last Price:
$115.54
Seasonality Move:
2.92%
Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
$292.34
Seasonality Move:
3.3%
Buy
64
Royal Bank of Canada (RY) is a Buy

Is Royal Bank of Canada a Buy, Sell or Hold?

  • The current Royal Bank of Canada [RY] share price is $113.60. The Score for RY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RY Stock Price Chart

What is Royal Bank of Canada's stock price today?

  • The Royal Bank of Canada share price today is $113.60
    The current trend is relatively stagnant and RY is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $283.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.68 Sell
Relative Strength Index (14 RSI): 45.75 Sell
Chaikin Money Flow: 290799 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.21 - 119.11) Sell
Bollinger Bands (100): (116.76 - 124.58) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 68.89 Buy
Chaikin Money Flow: 1798941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (239.98 - 259.48) Buy
Bollinger Bands (100): (240.26 - 271.94) Buy

RY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.3 Buy
20-day SMA: 114.67 Sell
50-day SMA: 118.1 Sell
200-day SMA: 117.46 Sell
8-day EMA: 113.2 Buy
20-day EMA: 114.49 Sell
50-day EMA: 117.19 Sell
200-day EMA: 115.88 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 251.71 Buy
20-day SMA: 247.77 Buy
50-day SMA: 256.39 Buy
200-day SMA: 250.79 Buy
8-day EMA: 256.23 Buy
20-day EMA: 252.43 Buy
50-day EMA: 253.95 Buy
200-day EMA: 242.96 Buy

Royal Bank of Canada Earnings Growth & RY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.13 per share, an increase this year of $0.88 per share, and an increase next year of $0.66 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.

Royal Bank of Canada Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):